The Value Signal — June 25, 2026

641 articles scanned · 15 high-signal

Signal Map

Executive Summary

Washington is tightening the screws on managed care, physician payment and Medicaid access while VBC operators are being pushed from pilots into proof, governance and downside-ready execution.

Utilization management and Medicare payment pressure are converging as a policy risk for plans and providers: Democrats are pressing CMS for more data on the WISeR Medicare AI prior authorization pilot amid concerns it is delaying beneficiary care, Healthcare Dive reports. MACRA’s record on Medicare physician payment reform remains mixed, underscoring that quality-based payment architecture has not solved clinician economics, Americanactionforum reports. Medicare Advantage scrutiny is also intensifying, with a Brown scholar offering Congress policy options to address overpayment issues and OPEN MINDS reporting that 95% of appealed Medicare Advantage skilled nursing facility denials were reversed.

VBC maturation and kidney care are the clearest operating signal: Alvarezandmarsal frames value-based care as moving from experimentation to enterprise discipline, while HCTTF highlights Strive Health’s kidney care model built on earlier identification, smarter coordination and better outcomes. Hcinnovationgroup reports that a coalition is calling for a long-term accountable kidney care model, reinforcing kidney disease as a proving ground for specialty VBC scale. Drug-pricing and Medicaid policy are adding margin volatility, with Kslaw reporting CMS has proposed rules for the Medicare Drug Price Negotiation Program, Healthcare Economist warning that foreign reference pricing can embed valuations that undermine global innovation, Hooper, Lundy & Bookman reporting CMS is narrowing Medicaid’s medical-frailty definition for work-requirement exemptions, and KFF projecting Medicare spending and solvency pressures in the 2026 Trustees Report.